Two paths to healing: organoids reveal sex-specific bone regeneration mechanisms
en-GBde-DEes-ESfr-FR

Two paths to healing: organoids reveal sex-specific bone regeneration mechanisms

09/04/2025 TranSpread

Bone regeneration continues to be a critical challenge in tissue engineering, with unpredictable outcomes often hindering clinical application. Current strategies overlook key factors such as donor differences and biological sex, both of which play a significant role in fracture healing. While cartilage intermediates have shown promise, the transition from cartilage to functional bone remains poorly understood, and a lack of quality metrics that are predictive of bone regeneration across patients hinder clinical implementation. Moreover, the influence of biological sex on bone repair, particularly in younger patients, remains an underexplored area. These challenges highlight the urgent need to understand how donor and sex-specific mechanisms affect bone regeneration.

Published (DOI: 10.1038/s41413-025-00418-z) on March 26, 2025, in Bone Research, a groundbreaking study led by KU Leuven in collaboration with international researchers examined bone-forming callus organoids derived from human periosteal cells. The team compared organoids from male and female donors, analyzing their extracellular matrix composition, transcriptomes, and secreted proteins. Their findings unveiled sex-dependent pathways in the cartilage-to-bone transition, offering fresh insights into personalized tissue engineering.

The study revealed striking differences between male and female-derived organoids in terms of cartilage formation. Male-derived organoids predominantly produced hypertrophic cartilage (HyC), featuring large, transparent structures rich in glycosaminoglycans and collagen II. Female-derived organoids, on the other hand, tended to develop fibrocartilage (FiC), consisting of smaller, denser tissues that lacked hypertrophic markers. Transcriptomic analysis uncovered a shared set of chondrogenic genes but distinct progenitor markers, suggesting early divergence in the differentiation process.

A key highlight of the study was the identification of 84 secreted proteins common to both cartilage-to-bone pathways, but not present in non bone-forming tissue, including agrin (AGRIN), osteopontin (SPP1), angiopoietin-like 4 (ANGPL4), autotaxin (NPP2) and bone morphogenic protein 1 (BMP1). These proteins are critical in driving bone maturation, angiogenesis and matrix remodeling.Despite their morphological differences, both male and female organoids successfully regenerated bone in mice, though the HyC organoids produced larger volumes. Notably, male cells exhibited faster proliferation and deposited more extracellular matrix, highlighting the role of biological sex in progenitor cell activation.

Prof. Ioannis Papantoniou, senior author of the study, emphasized the significance of these findings: "Our work bridges the gap between developmental biology and clinical translation. By decoding sex-specific repair mechanisms, we can design smarter living implants tailored to individual but also groups of patients. The secreted protein panel is a game-changer for monitoring implant quality without invasive sampling."

The implications of this research are profound, offering the potential to revolutionize treatments for bone defects with sex-specific or donor-matched therapies. The identification of secreted protein biomarkers could streamline the manufacturing process, reducing costs and enhancing the reliability of advanced therapeutic products. Clinically, these advancements could benefit younger patients (aged 25-45), who often struggle with non-union fractures. Moving forward, future research will focus on validating these biomarkers in larger animal models and exploring the influence of hormones. Ultimately, this study underscores the crucial role of biological sex in regenerative medicine, advocating for a shift toward personalized approaches in tissue engineering.

###

References

DOI

10.1038/s41413-025-00418-z

Original Source URL

https://doi.org/10.1038/s41413-025-00418-z

Funding information

The micro (or nano)-CT images were generated on the X-ray computed tomography facility of the Department of Development and Regeneration of the KU Leuven, financed by the Hercules Foundation (project AKUL/13/47). The project leading to this publication has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 874837. This work was supported by the Flemish Government (department of Economy, Science and Innovation) through the Regenerative Medicine Crossing Borders initiative. Images were recorded on a Zeiss LSM 780 – SP Mai Tai HP DS (Cell and Tissue Imaging Cluster (CIC), Supported by Hercules AKUL/11/37 and FWO G.0929.15 to Pieter Vanden Berghe, University of Leuven. This work was supported by Interne Fondsen KU Leuven/Internal Funds KU Leuven grant numbers C24M/22/058.

About Bone Research

Bone Research was founded in 2013. As a new English-language periodical, Bone Research focuses on basic and clinical aspects of bone biology, pathophysiology and regeneration, and supports the foremost discoveries resulting from basic investigations and clinical research related to bone. The aim of the Journal is to foster the worldwide dissemination of research in bone-related physiology, pathology, diseases and treatment.

Paper title: Callus organoids reveal distinct cartilage to bone transition mechanisms across donors and a role for biological sex
Attached files
  • Experimental design and methods overview. a Protocol timeline. b The process of cell aggregation and organoid formation. The dotted line represents the organoid edge. Scalebar = 200 µm. c organoid fusion leading to the formation of macro-scale assembloids. d Alcian blue staining of cartilaginous extracellular matrix (ECM) of an assembloid after 24 h, and (e) safranin-o/fastgreen staining of sulphated glycosaminoglycans (sGAG). Scalebar = 500 µm. f Experimental design to assess the requirements for cartilage-to-bone transition. For chondrogenic treatment, cells from 10 donors were evaluated (5 male, 5 female, aged 16–29). As undifferentiated control, 5 donors were evaluated (3 male, 2 female, age 21–29).
09/04/2025 TranSpread
Regions: North America, United States, Europe, Belgium
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by AlphaGalileo Terms Of Use Privacy Statement